Turn LinkedIn into your partnership pipeline.
B2BCream scores companies, finds the right contacts, and drafts personalized outreach - based on your therapeutic scope and the AEMPS database. Built for Business Development managers in pharma.
Pharma BD is too manual - and the cost shows up in your closed deals.
Hours lost on manual research
You scroll LinkedIn looking for the right BD lead, jump to ATC tables, cross-check AEMPS, and start over for every new molecule.
Generic outreach gets ignored
Pharma decision-makers receive 30+ messages a week. Templates without therapeutic context land in the trash within seconds.
Pipeline scattered across tools
Your team's conversations live in inboxes, spreadsheets, and heads. No one knows who has talked to whom - or what was promised.
Built for the way pharma BD actually works.
Not another generic CRM bolted on. B2BCream lives where your team already works - LinkedIn - and is fluent in molecules, ATC codes, and AEMPS.
Targeting that knows your scope
Upload your portfolio. B2BCream maps your therapeutic areas using ATC codes and AEMPS records, then ranks the companies that matter most for partnerships.
- ATC scope auto-detected
- Filters that learn your domain
- Saved strategies per molecule
Scoring that reads LinkedIn
Open any LinkedIn profile. B2BCream shows a 0-100 fit score combining the company match, the person's role, and your target archetype.
- Company score on AEMPS data
- Role match for BD / Ops / GM
- Right person, right time
Pipeline that stays in sync
Every connection request and message is auto-tracked. Your team sees the full picture from one dashboard, with tasks assignable across the team.
- Auto-tracking inside LinkedIn
- Assign leads across the team
- Status from outreach to close
Three steps from your portfolio to a meeting.
Bring your portfolio
Drop your product list or pick molecules. B2BCream locks the therapeutic scope (ATC) so every search stays inside your domain - cardio, oncology, antithrombotics, whatever you sell.
Filter and rank companies
Combine raw fields and computed metrics - competition, coverage, AEMPS share - over your scope. Save the search as a strategy you can reuse and share with your team.
| # | Company | AEMPS reg. | Score |
|---|---|---|---|
| 1 | Sanofi | 14 | 92 |
| 2 | BMS | 9 | 88 |
| 3 | Bayer | 11 | 85 |
| 4 | Boehringer | 8 | 81 |
| 5 | Pfizer | 7 | 76 |
Open LinkedIn - B2BCream scores the room
Click a company in the ranking. B2BCream takes you to its LinkedIn employees page, scores each contact against your archetype, and drafts the first message in your voice.
Hi Marta - I noticed Sanofi holds 14 active AEMPS records in B01A. We have three antithrombotic assets that complement your portfolio. Worth a 15-minute chat to compare notes?
Join the waitlist.
We are onboarding a small group of pharma BD teams during the private beta. Tell us a bit about you and we will reach out when your slot opens.
- Free during beta * pricing announced before launch
- 1-to-1 onboarding session with our team
- Direct line to shape the product roadmap